Novartis plans to reorganize parts of its domestic workforce, eliminating as many as 500 jobs in its pharmaceutical division in an effort to cut costs to support new product launches. Most of the job cuts will be in support functions at its headquarters, as well as operational roles in development.   According to the company, the changes will include an equal number of jobs being cut and created in Switzerland this year, and expects its overall headcount in the country to remain at  approximatel...